Alfresa Holdings Corporation (ALFRY) Stock

About Alfresa Holdings Corporation

Tokyo, Japan-based Alfresa Holdings Corporation, established in 2003, is a diversified entity operating domestically and internationally within the healthcare industry. The company's core activities encompass the production, wholesale distribution, marketing, and global trade of pharmaceuticals, diagnostic agents, and medical equipment. Alfresa operates through distinct wholesale divisions, including an ethical pharmaceuticals segment that supplies hospitals, clinics, and pharmacies with essential diagnostic reagents, medical devices, and prescription drugs. Another division specializes in self-medication products, delivering over-the-counter medicines, health foods, and nutritional supplements to drugstores and pharmacies. Beyond distribution, Alfresa is actively involved in manufacturing and commercializing active pharmaceutical ingredients, finished drug products, diagnostic reagents, and medical devices, alongside offering contract manufacturing services for pharmaceuticals. Additionally, its medical-related ventures include managing dispensing pharmacies and other ancillary healthcare services.

Alfresa Holdings Corporation is headquartered in JP.

Alfresa Holdings Corporation (ALFRY) stock trades at $13.55 with a market capitalization of $2.46B. The stock is valued at a price-to-earnings (P/E) ratio of 10.09, price-to-book of 0.83, price-to-sales of 0.14. Over the past 52 weeks the stock has ranged between $12.42 and $16.81, and currently trades 19.4% below its 52-week high. It pays a dividend yielding 3.10%.

On profitability, Alfresa Holdings Corporation generates a return on equity (ROE) of 8.48%, return on capital employed of 6.36%, an operating margin of 1.17%, a net profit margin of 1.34%.

Official website: www.alfresa.com